AI assistant
Jagsonpal Pharmaceuticals Limited — Call Transcript 2025
May 7, 2025
62844_rns_2025-05-07_d03174c0-bf01-4120-b062-42b0e2ccc938.pdf
Call Transcript
Open in viewerOpens in your device viewer
A CSR Initiative
==> picture [50 x 28] intentionally omitted <==
JAGSONPAL PHARMACEUTICALS LIMITED
==> picture [39 x 48] intentionally omitted <==
Corporate Office: Nimai Tower, 3[rd] Floor, Plot No. 412-415, Phase-IV, Udyog Vihar, Gurugram -122015, Haryana (India)
May 07, 2025
The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Bandra Mumbai-400 001 (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM
Subject: Audio Recording of Jagsonpal Pharmaceuticals Limited Q4 FY25 Earnings Conference Call on May 07, 2025 at 4:00 P.M.
Dear Sir/ Madam,
In continuation to our earlier intimation dated April 30, 2025, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Jagsonpal Pharmaceuticals Limited Q4 FY25 Earnings Conference Call held on May 07, 2025 at 4:00 P.M. for discussion of Q4 FY25 Financial Results is available on the Company’s website at below link:
https://www.jagsonpal.com/investor-relations/earning-calls/
We request you to take the above on record.
Thanking you,
For Jagsonpal Pharmaceuticals Limited
PRATHA Digitally signed by PRATHAM RAWAL M RAWAL Date: 2025.05.07 18:13:02 +05'30'
Pratham Rawal Company Secretary & Compliance Officer
Ph.: +91 124 4406710; E-mail: [email protected]; Website: www.jagsonpal.com CIN NO. L74899DL1978PLC009181 Regd. Office: T-210 J, Shahpur Jat, New Delhi - 110049 (India)